ES2192840T3 - Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal. - Google Patents

Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.

Info

Publication number
ES2192840T3
ES2192840T3 ES99916994T ES99916994T ES2192840T3 ES 2192840 T3 ES2192840 T3 ES 2192840T3 ES 99916994 T ES99916994 T ES 99916994T ES 99916994 T ES99916994 T ES 99916994T ES 2192840 T3 ES2192840 T3 ES 2192840T3
Authority
ES
Spain
Prior art keywords
fermented
laxant
osmotic
treat
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99916994T
Other languages
English (en)
Inventor
Denis E Corpet
Sylviane Tache
Geraldine Parnaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Original Assignee
Institut National de la Recherche Agronomique INRA
Ecole Nationale Veterinaire de Toulouse ENVT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9813450A external-priority patent/FR2784896B1/fr
Application filed by Institut National de la Recherche Agronomique INRA, Ecole Nationale Veterinaire de Toulouse ENVT filed Critical Institut National de la Recherche Agronomique INRA
Application granted granted Critical
Publication of ES2192840T3 publication Critical patent/ES2192840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Utilización de un laxante osmótico no fermentado como agente activo para la preparación de un medicamento destinado al tratamiento y/o a la prevención de los cánceres de colon y/o de recto.
ES99916994T 1998-10-27 1999-05-05 Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal. Expired - Lifetime ES2192840T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9813450A FR2784896B1 (fr) 1998-10-27 1998-10-27 Utilisation du polyethylene-glycol dans le traitement et la prevention des cancers colorectaux
FR9903240A FR2784897B1 (fr) 1998-10-27 1999-03-16 Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux

Publications (1)

Publication Number Publication Date
ES2192840T3 true ES2192840T3 (es) 2003-10-16

Family

ID=26234618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99916994T Expired - Lifetime ES2192840T3 (es) 1998-10-27 1999-05-05 Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.

Country Status (13)

Country Link
US (1) US6939563B2 (es)
EP (1) EP1124566B1 (es)
AT (1) ATE232390T1 (es)
AU (1) AU758348B2 (es)
BR (1) BR9914794A (es)
CA (1) CA2347170C (es)
DE (1) DE69905384T2 (es)
DK (1) DK1124566T3 (es)
ES (1) ES2192840T3 (es)
FR (1) FR2784897B1 (es)
NZ (1) NZ511150A (es)
PT (1) PT1124566E (es)
WO (1) WO2000024407A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4535234B2 (ja) * 2001-10-29 2010-09-01 味の素株式会社 腸管洗浄製剤
EP1744767A4 (en) * 2004-04-20 2008-08-13 Univ Chicago THERAPEUTIC DELIVERY SYSTEM WITH PEG-LIKE CONNECTION WITH HIGH MOLECULAR WEIGHT
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9198847B2 (en) * 2004-11-05 2015-12-01 The Procter & Gamble Company Personal care composition containing a non-guar galactomannan polymer derivative and an anionic surfactant system
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
EP1877039A4 (en) * 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
EP2012804A4 (en) * 2006-04-24 2012-07-04 Bruce Medical Ab ANTICANCER AGENTS BASED ON POLYMERS
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
GB201018650D0 (en) * 2010-11-04 2010-12-22 Norgine Bv Methods and compositions
CA2947434A1 (en) 2014-04-29 2015-11-05 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
WO2016140981A1 (en) 2015-03-02 2016-09-09 Colonaryconcepts Llc Compounds and methods for peg metabolite and peg breakdown product assays
EP3934661B1 (en) 2019-03-05 2025-04-02 Dow Global Technologies LLC Inducing caspase activity for treating colorectal cancer with polymers
WO2020180555A1 (en) * 2019-03-05 2020-09-10 Dow Global Technologies Llc Polyethyleneglycol derivatives for inducing caspase activity
WO2020180581A1 (en) 2019-03-05 2020-09-10 Dow Global Technologies Llc Inducing caspase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물

Also Published As

Publication number Publication date
US20010051659A1 (en) 2001-12-13
DE69905384T2 (de) 2003-11-27
DE69905384D1 (de) 2003-03-20
NZ511150A (en) 2003-03-28
BR9914794A (pt) 2001-07-10
EP1124566B1 (fr) 2003-02-12
FR2784897A1 (fr) 2000-04-28
PT1124566E (pt) 2003-06-30
WO2000024407A1 (fr) 2000-05-04
CA2347170A1 (fr) 2000-05-04
AU3528399A (en) 2000-05-15
DK1124566T3 (da) 2003-06-02
AU758348B2 (en) 2003-03-20
CA2347170C (fr) 2011-09-20
ATE232390T1 (de) 2003-02-15
US6939563B2 (en) 2005-09-06
EP1124566A1 (fr) 2001-08-22
FR2784897B1 (fr) 2002-11-29

Similar Documents

Publication Publication Date Title
ES2192840T3 (es) Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.
GB9807639D0 (en) Anti-inflammatory agents
NO20014662L (no) Fremgangsmåter og preparater for behandling av faste tumorer
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
PT1161248E (pt) Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
EA200200595A1 (ru) Лекарственная форма с высвобождением лекарства под действием гидрогеля
GB0013674D0 (en) Therapeutic use
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
MY164077A (en) Compositions and uses of et743 for treating cancer
CA2411922A1 (en) Composition for pain mediation and apparatus and method of use thereof
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
ATE313334T1 (de) Behandlung von tumoren mit photodynamischer therapie
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
MXPA01013460A (es) Formulaciones topicas que comprenden agentes de penetracion de la piel y uso de las mismas.
GEP20043231B (en) Resorcinol Composition
RU94024337A (ru) Антиметастатическое средство
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
SE9700617D0 (sv) New composition
PT874630E (pt) Terapia combinada de um inibidor da topoisomerase ii e um derivado da bis-dioxipiperazina